Optometrists in Tecumseh, MI Accepting Medicare
10 Optometrists found. Showing 1 - 10
 Dana E Gillin, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 112 N Evans St, Suite 2, Tecumseh, MI 49286 Phone: 517-424-1010 Fax: 517-592-5048 |
 Gillin Eye Care Pc Optometrist Medicare: Medicare Enrolled Practice Location: 112 N Evans St, Suite 2, Tecumseh, MI 49286 Phone: 517-424-1010 |
Cunningham Vision Centers Optometrist Medicare: Not Enrolled in Medicare Practice Location: 138 W Chicago Blvd, Tecumseh, MI 49286 Phone: 517-423-2148 Fax: 517-423-2370 |
Nicholas Joseph Carr, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 138 W Chicago Blvd, Tecumseh, MI 49286 Phone: 517-423-2148 |
Dr. Thomas G Cunningham, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 138 W Chicago Blvd, Tecumseh, MI 49286 Phone: 517-423-2148 Fax: 517-423-7120 |
Eye Care Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 904 W Chicago Blvd, Suite A, Tecumseh, MI 49286 Phone: 517-423-2001 Fax: 517-423-7030 |
 Dr. Clare Masson, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 138 W Chicago Blvd, Tecumseh, MI 49286 Phone: 517-423-2148 Fax: 517-423-7120 |
Anklin Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 904 W Chicago Blvd Ste A, Tecumseh, MI 49286 Phone: 517-423-7447 Fax: 517-423-7030 |
Bennett Optometry Llc Optometrist Medicare: Medicare Enrolled Practice Location: 138 W Chicago Blvd, Tecumseh, MI 49286 Phone: 517-423-2148 |
Dr. Eric Thomas Anklin, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 904 W Chicago Blvd, Ste A, Tecumseh, MI 49286 Phone: 517-423-2001 Fax: 517-423-7030 |
News Archive
FDA grants Orphan Drug Designation to TxCell's Col-Treg for treatment of autoimmune uveitis
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted Orphan Drug Designation (ODD) to TxCell's Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of chronic non-infectious uveitis.
Capsule research could transform treatment for C. difficile infections
An Alberta-led clinical trial has shown Fecal Microbiota Transplant (FMT) is as effective in treating clostridium difficile (C. difficile) infections whether delivered by colonoscopy or by swallowing capsules.
Scientists crack genetic code for Schistosoma haematobium
Scientists have cracked the genetic code and predicted some high priority drug targets for the blood parasite Schistosoma haematobium, which is linked to bladder cancer and HIV/ AIDS and causes the insidious urogenital disease schistosomiasis haematobia in more than 112 million people in Africa.
Northwest Biotherapeutics initiates Phase III trial of DCVax-L in Germany
Northwest Biotherapeutics, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, announced today that it has initiated the Phase III trial of DCVax-L in Germany.
L.A. Fitness to open eighth sports club in Indiana
L.A. Fitness is pleased to announce the opening of its newest sports club, a 45,000 square foot facility in Lawrence, Indiana. The club is at the intersection of Pendleton Pike and Mitthoefer Rd.
› Verified 6 days ago
Chiropractors
Optometrists
Physical Therapists
Occupational Therapists
Speech-Language Pathologists